跳至主要内容
临床试验/ISRCTN88782125
ISRCTN88782125已完成3 期

STOPAH: STeroids Or Pentoxifyline for Alcoholic Hepatitis

Southampton University Hospitals NHS Trust (UK)0 个研究点目标入组 1,068 人开始时间: 2009年6月26日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
1,068

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Clinical alcoholic hepatitis:
  • 1.1. Serum bilirubin greater than 80 µmol/L
  • 1.2. History of excess alcohol (greater than 80 g/day male, greater than 60 g/day female)
  • 2. Less than 4 weeks from admission to hospital
  • 3. Discriminant Function (DF) greater than or equal to 32
  • 4. Informed consent
  • 5. Minimum 18 years old, no upper limit, either sex

排除标准

  • 1. Abstinence of more than 6 weeks prior to randomisation
  • 2. Duration of jaundice greater than 3 months
  • 3. Other causes of liver disease
  • 4. Evidence of current malignancy (except non-melanotic skin cancer)
  • 5. Previous entry into the study, or use of either prednisolone or PTX within 6 months
  • 6. Aspartate aminotransferase (AST) greater than 500 or alanine aminotransferase (ALT) greater than 300
  • 7. Patients with a serum creatinine greater than 500 µmol/L or requiring renal support
  • 8. Patients dependent upon inotropic support
  • 9. Active gastro-intestinal haemorrhage and untreated sepsis

研究者

发起方
Southampton University Hospitals NHS Trust (UK)

相似试验